Jade Road Investments Limited NPV (DI) (JADE)

Sector:

Financials

 1.38p
   
  • Change Today:
      0.000p
  • 52 Week High: 2.16p
  • 52 Week Low: 1.10p
  • Currency: UK Pounds
  • Shares Issued: 355.55m
  • Volume: 0
  • Market Cap: £4.89m
  • RiskGrade: 184

Adamas leads funding round for Singapore health-tech project DocDoc

By Josh White

Date: Monday 19 Mar 2018

LONDON (ShareCast) - (ShareCast News) - Asia-focused investment firm Adamas Finance Asia announce an investment in a new project, DocDoc, on Monday.
The AIM-traded company said the investment was in line with its revised strategy, following the appointment of Harmony Capital as its new manager in May last year, which aimed to provide investors with a diverse portfolio of pan-Asian income producing assets with capital gain potential.

Its board said it believed that DocDoc was Asia's leading "patient empowerment company".

The company leveraged proprietary data and clinical informatics across a network of physicians and hospitals, to support patients in finding high quality medical care, Adamas explained.

Headquartered in Singapore, DocDoc connected and represented an "extensive healthcare network", the board explained, with more than 23,000 physicians, 700 clinics and 100 hospitals.

DocDoc was established to address a significant unmet need in the marketplace for patient empowerment, which Adamas said resulted in efficiently-priced treatments, better outcomes and improved experiences for patients across Asia.

The benefits of DocDoc's proprietary database, algorithms and data models, combined with its business and customer service processes, were said to be beneficially impacting an underserved need in the health insurance sector, as evidenced by the execution of agreements with several of the leading insurers in the region.

Adamas was the lead investor in DocDoc's latest $5.45m round of investment, via a $2m subscription to a convertible bond offering.

"We are delighted to make our first investment following the change to our investment policy and a series of disposals in 2017," said Adamas chairman John Croft.

"The transformation of the Adamas portfolio is underway and the DocDoc investment represents an important step in reshaping the portfolio.

"DocDoc is an exciting next generation digital health platform, adeptly fulfilling patient demand and supported by partnerships with leading players such as the Ping An Group and Prudential."

DocDoc's co-founder and CEO, Cole Sirucek, said the company was "thrilled" to welcome Adamas to the DocDoc family.

"Their investment has come at a most opportune time as we scale our value-added doctor discovery service in conjunction with the region's largest insurance companies.

"The Adamas and Harmony Capital team have done a great job helping us put this financing together and we look forward to them adding significant value going forward," Sirucek explained.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

JADE Market Data

Currency UK Pounds
Share Price 1.38p
Change Today 0.000p
% Change 0.00 %
52 Week High 2.16p
52 Week Low 1.10p
Volume 0
Shares Issued 355.55m
Market Cap £4.89m
RiskGrade 184

JADE Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.11% above the market average71.11% above the market average71.11% above the market average71.11% above the market average71.11% above the market average
47.66% above the sector average47.66% above the sector average47.66% above the sector average47.66% above the sector average47.66% above the sector average
Price Trend
57.45% below the market average57.45% below the market average57.45% below the market average57.45% below the market average57.45% below the market average
53.45% below the sector average53.45% below the sector average53.45% below the sector average53.45% below the sector average53.45% below the sector average
Income Not Available
Growth Not Available

JADE Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

JADE Key Personnel

Chair John Michael Croft

Top of Page